Immunotherapy and Precision Oncology BIOL5342

  • Academic Session: 2019-20
  • School: Cancer Sciences
  • Credits: 20
  • Level: Level 5 (SCQF level 11)
  • Typically Offered: Semester 2
  • Available to Visiting Students: No
  • Available to Erasmus Students: No

Short Description

The course will enable the students to gain in depth knowledge on the use of state of the art 'omic' technologies in stratifying patients into prognosis and treatment groups, the use of personalised medicine, latest targeted treatment regimens and the rapidly developing field of immunotherapy to target cancer

Timetable

Teaching takes place over 5 weeks in semester 2 with students attending both seminars and tutorials.

Requirements of Entry

None

Excluded Courses

None

Co-requisites

None

Assessment

1. Compile a structured essay 2500-3000 words approx (80%)

 

2. Oral Presentation (20%)

Course Aims

This course aims to provide students with an in-depth knowledge and understanding of latest approaches in treating cancer patients. It will explore the latest diagnostic techniques used to stratify patients for precision medicine treatment approaches.

Intended Learning Outcomes of Course

By the end of this course students will be able to:

1. Critical evaluate the use of precision oncology and its application for personalized medicine and patient care;

2. Critically discuss the use of targeted therapies used in the cancer field.

3. Develop knowledge and expertise in immunotherapy strategies and their application in the cancer field.

4. Critically evaluate the literature and demonstrate scientific writing skills by effectively writing an essay on one of the taught topics and gain skills in communicating with impact.

Minimum Requirement for Award of Credits

Students must submit at least 75% by weight of the components (including examinations) of the course's summative assessment.